Oxford Biomedica plc
Status: Publicly traded
Direct answer
Oxford Biomedica plc is publicly traded on LSE under the ticker OXB.L.
Oxford Biomedica plc is a biopharmaceutical firm focused on the discovery, advancement, and sophisticated bioprocessing of innovative cell and gene therapies. Operating globally, with a strong presence across Europe, the company organizes its activities into two segments: Platform and Product. Its proprietary LentiVector platform technology facilitates the integration of genes into non-dividing cells, such as...
Can you invest in Oxford Biomedica plc?
Yes. Oxford Biomedica plc trades publicly on LSE as OXB.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Oxford Biomedica plc
Detailed equity research is provided by MarketSnap.